ASRT
Assertio Holdings Inc
NASDAQ · Pharmaceuticals
$12.74
+1.12 (+9.64%)
Open$11.69
Previous Close$11.62
Day High$12.95
Day Low$11.61
52W High$21.20
52W Low$11.43
Volume—
Avg Volume465.1K
Market Cap81.75M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+88.1% upside
Current
$12.74
$12.74
Target
$23.96
$23.96
$13.92
$23.96 avg
$25.97
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 51.42M | 46.50M | 50.98M |
| Net Income | 12.66M | 11.15M | 14.28M |
| Profit Margin | 24.6% | 24.0% | 28.0% |
| EBITDA | 19.18M | 17.15M | 17.67M |
| Free Cash Flow | 16.80M | 10.93M | 11.61M |
| Rev Growth | -9.1% | +24.8% | -5.2% |
| Debt/Equity | 0.72 | 0.73 | 0.85 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |